KBC Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $530M | Sell |
576,203
-127,814
| -18% | -$130M | 1.33% | 9 |
|
|
2025
Q4 | $757M | Buy |
704,017
+12,127
| +2% | +$11.6M | 1.73% | 9 |
|
|
2025
Q3 | $528M | Buy |
691,890
+82,523
| +14% | +$61.4M | 1.27% | 11 |
|
|
2025
Q2 | $475M | Buy |
609,367
+54,685
| +10% | +$42.5M | 1.28% | 10 |
|
|
2025
Q1 | $458M | Sell |
554,682
-34,327
| -6% | -$28.6M | 1.42% | 8 |
|
|
2024
Q4 | $455M | Buy |
589,009
+23,174
| +4% | +$19.2M | 1.25% | 11 |
|
|
2024
Q3 | $501M | Sell |
565,835
-56,757
| -9% | -$51M | 1.51% | 8 |
|
|
2024
Q2 | $564M | Buy |
622,592
+143,341
| +30% | +$115M | 1.7% | 8 |
|
|
2024
Q1 | $373M | Sell |
479,251
-95,144
| -17% | -$67.7M | 1.18% | 10 |
|
|
2023
Q4 | $335M | Buy |
574,395
+24,607
| +4% | +$14.4M | 1.19% | 10 |
|
|
2023
Q3 | $295M | Sell |
549,788
-96,151
| -15% | -$49.5M | 1.21% | 11 |
|
|
2023
Q2 | $303M | Buy |
645,939
+79,773
| +14% | +$33.5M | 1.25% | 10 |
|
|
2023
Q1 | $194M | Sell |
566,166
-131,501
| -19% | -$44.3M | 0.83% | 21 |
|
|
2022
Q4 | $255M | Sell |
697,667
-99,932
| -13% | -$35.4M | 1.24% | 11 |
|
|
2022
Q3 | $258M | Buy |
797,599
+193,167
| +32% | +$61.2M | 1.34% | 9 |
|
|
2022
Q2 | $196M | Sell |
604,432
-62,893
| -9% | -$18.9M | 0.98% | 17 |
|
|
2022
Q1 | $191M | Sell |
667,325
-66,424
| -9% | -$17.1M | 0.76% | 20 |
|
|
2021
Q4 | $203M | Buy |
733,749
+174,964
| +31% | +$44.4M | 0.67% | 31 |
|
|
2021
Q3 | $129M | Sell |
558,785
-450,693
| -45% | -$111M | 0.47% | 49 |
|
|
2021
Q2 | $232M | Sell |
1,009,478
-79,502
| -7% | -$16M | 0.42% | 56 |
|
|
2021
Q1 | $203M | Sell |
1,088,980
-200,048
| -16% | -$39.1M | 0.41% | 53 |
|
|
2020
Q4 | $1.19B | Buy |
1,289,028
+635,674
| +97% | +$94.9M | 0.51% | 41 |
|
|
2020
Q3 | $96.7M | Buy |
653,354
+164,022
| +34% | +$25.4M | 0.29% | 80 |
|
|
2020
Q2 | $80.3M | Buy |
489,332
+86,147
| +21% | +$13.2M | 0.27% | 82 |
|
|
2020
Q1 | $55.9M | Buy |
403,185
+61,221
| +18% | +$8.41M | 0.47% | 41 |
|
|
2019
Q4 | $44.9M | Sell |
341,964
-86,989
| -20% | -$10.1M | 0.28% | 78 |
|
|
2019
Q3 | $48M | Sell |
428,953
-136,737
| -24% | -$15.2M | 0.35% | 57 |
|
|
2019
Q2 | $62.7M | Buy |
565,690
+51,131
| +10% | +$6.02M | 0.48% | 42 |
|
|
2019
Q1 | $66.8M | Buy |
514,559
+201,587
| +64% | +$24.5M | 0.55% | 29 |
|
|
2018
Q4 | $36.2M | Buy |
312,972
+5,267
| +2% | +$588K | 0.4% | 59 |
|
|
2018
Q3 | $33M | Sell |
307,705
-171,559
| -36% | -$17.2M | 0.25% | 106 |
|
|
2018
Q2 | $40.9M | Sell |
479,264
-57,893
| -11% | -$4.76M | 0.36% | 62 |
|
|
2018
Q1 | $41.6M | Sell |
537,157
-2,883
| -0.5% | -$232K | 0.38% | 60 |
|
|
2017
Q4 | $45.6M | Sell |
540,040
-244,519
| -31% | -$20.8M | 0.39% | 61 |
|
|
2017
Q3 | $67.1M | Buy |
784,559
+34,560
| +5% | +$2.83M | 0.61% | 25 |
|
|
2017
Q2 | $61.7M | Sell |
749,999
-7,290
| -1% | -$595K | 0.6% | 28 |
|
|
2017
Q1 | $63.7M | Buy |
757,289
+409,273
| +118% | +$32.8M | 0.58% | 29 |
|
|
2016
Q4 | $25.6M | Sell |
348,016
-79,175
| -19% | -$5.9M | 0.25% | 96 |
|
|
2016
Q3 | $34.3M | Buy |
427,191
+148,599
| +53% | +$11.9M | 0.41% | 56 |
|
|
2016
Q2 | $21.9M | Buy |
278,592
+13,770
| +5% | +$1.04M | 0.31% | 75 |
|
|
2016
Q1 | $19.1M | Buy |
264,822
+18,823
| +8% | +$1.42M | 0.32% | 71 |
|
|
2015
Q4 | $20.7M | Buy |
245,999
+27,720
| +13% | +$2.3M | 0.38% | 56 |
|
|
2015
Q3 | $18.3M | Buy |
218,279
+7,128
| +3% | +$602K | 0.37% | 68 |
|
|
2015
Q2 | $17.6M | Buy |
211,151
+21,677
| +11% | +$1.65M | 0.23% | 121 |
|
|
2015
Q1 | $13.8M | Sell |
189,474
-280,121
| -60% | -$19.9M | 0.18% | 159 |
|
|
2014
Q4 | $32.4M | Buy |
469,595
+92,660
| +25% | +$6.25M | 0.39% | 60 |
|
|
2014
Q3 | $24.4M | Sell |
376,935
-174,581
| -32% | -$11.1M | 0.85% | 9 |
|
|
2014
Q2 | $34.3M | Sell |
551,516
-49,733
| -8% | -$2.97M | 0.39% | 49 |
|
|
2014
Q1 | $35.4M | Sell |
601,249
-70,329
| -10% | -$3.92M | 0.56% | 35 |
|
|
2013
Q4 | $34.3M | Buy |
671,578
+130,189
| +24% | +$6.52M | 0.52% | 37 |
|
|
2013
Q3 | $27.2M | Buy |
541,389
+56,929
| +12% | +$2.98M | 0.44% | 48 |
|
|
2013
Q2 | $23.8M | Buy |
+484,460
| New | +$26.4M | 0.44% | 45 |
|
Other funds holding LLY
VCM
VPM
KBC Group's LLY Position: Q1 2026 in Review
KBC Group reduced its Eli Lilly (LLY) stake by 18% in Q1 2026, selling an estimated $130M and leaving 576,203 shares worth $530M. The position accounts for 1.33% of the portfolio, ranked #9.
KBC Group first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.19B in Q4 2020. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- KBC Group held 576,203 shares of Eli Lilly worth $530M as of Q1 2026.
- KBC Group sold 127,814 Eli Lilly shares in Q1 2026, an estimated $130M.
- Eli Lilly made up 1.33% of KBC Group's portfolio in Q1 2026, its #9 holding.
- KBC Group first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- KBC Group's Eli Lilly position peaked at $1.19B in Q4 2020.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.